Navigation Links
Veteran Pharmaceutical Executives Form New American Therapeutics, Inc.

CRANFORD, N.J., Oct. 27 /PRNewswire/ -- Alan L. Rubino, former Hoffmann-La Roche senior executive and former CEO of two emerging pharmaceutical companies, and Timothy G. Rothwell, former Chairman, CEO, and President of sanofi-aventis U.S., have collaborated to form New American Therapeutics, Inc.  

Mr. Rubino will serve as CEO and President, while Mr. Rothwell will function as the company's Chairman.  The company's key emphasis will be on establishing a general specialty pharmaceutical presence built around select physician specialties and associated patient therapeutic needs.

"The decision to start New American Therapeutics was driven by changing industry trends and market forces," said Mr. Rubino. "We saw an opportunity to create a new and agile business model that is flexible and versatile enough to navigate the challenges in today's dynamic environment. The industry experience and performance track records of our leaders, board members, and management team provide us with a keen understanding of what works and what doesn't."

New American Therapeutics is being funded through a partnership with Deerfield Management Company, L.P.   Deerfield is a privately owned healthcare investment management firm that was founded in 1994 and is based in New York, N.Y.  Piper Jaffray & Co. served as exclusive financial advisor to the company on its initial financing transaction.

On October 1, 2010, New American Therapeutics announced that it acquired all U.S. rights to manufacture, market and sell the topical antiviral drug Denavir® (  A proven treatment for cold sores since 1996, Denavir is the first product the company will be marketing and distributing.

"This was an opportunistic acquisition for us that met very specific criteria," explained Mr. Rubino. "It is an excellent therapeutic agent that, despite not receiving an adequate marketing investment, was still maintaining nearly a 50% prescription share of the topical antiviral market. That speaks volumes about physician and patient satisfaction."

Because of its current level of use in the marketplace coupled with a renewed commercial effort, Denavir is expected to provide a solid financial foundation for New American Therapeutics and will serve as the company's initial anchor product.

Beyond Denavir, New American Therapeutics will be pursuing marketed and launched assets that will benefit from the company's commercialization model. "Our progressive business strategy is already in the execution phase," said Mr. Rubino. "We will be tapping into our deep relationships within many U.S. and international pharmaceutical companies to explore product acquisition opportunities and other collaborations. We intend to move quickly and bring in products at a steady rate, which will allow us to grow in a rapid, yet calculated manner."

For more information about New American Therapeutics, visit or call 908-282-7441.

About New American Therapeutics, Inc.New American Therapeutics, Inc. is a privately held general specialty pharmaceutical company based in Cranford, N.J. that acquires, markets and distributes products that have the potential to improve outcomes for patients and provide more treatment options for physicians. CONTACT:Alan L. Rubino  908-372-8108Email:

SOURCE New American Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Wound Management Technologies, Inc. Furthers its Government Initiatives and Business Development within the Veterans Health Administration
2. Prolong Pharmaceuticals Names Industry Veteran Glenn Kazo President
3. Medical Cannabis University™ Launches, Puts Thousands Back to Work to Help Veterans and the Chronically Ill
4. ZS Associates Appoints Pharmaceutical Industry Veteran to Serve the Firms Growing Client Base in Germany
5. Veteran Affairs Announces That Redsense Alarm Will be Mandatory on Patients by November 1, 2010
6. Veterans Administration Health Care System Purchases 15 Zargis Cardioscan Systems
7. Sperian Respiratory Protection USA Awarded a 65,000 Reusable Respirator Order by the Veterans Health Administration
8. Veteran International Health Care Executive Appointed CEO of BeneChill(R)
9. PTCB Certification Required for Pharmacy Technician Employment by Department of Veterans Affairs
10. Department of Veterans Affairs Requires PTCB Certification for Pharmacy Technician Employment
11. MyPunchbowl Expands Leadership Team With Veterans of and Pizza Hut
Post Your Comments:
(Date:6/24/2016)... 24, 2016 Research and Markets has ... Companion Diagnostic Tests" report to their offering. ... Diagnostics The World Market for Companion Diagnostics ... diagnostics. Market analysis in the report includes the following: ... Vitro Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop a weight ... app plans to fix the two major problems leading the fitness industry today:, ... program , They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, ... work on several important health care topics including advance care planning, healthcare costs ...
(Date:6/25/2016)... ... , ... The temporary closing of Bruton Memorial Library on June 21 due to a possible ... often overlooked aspect of head lice: the parasite’s ability to live away from a human ... but a necessary one in the event that lice have simply gotten out of control. ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
Breaking Medicine News(10 mins):